Beth Hecht insider trades
Open-market stock purchases and sales by Beth Hecht, See Remarks at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Oct 1, 2015.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +107%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $141K |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $134K |
| Jun 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $101K |
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $104K |
| Apr 1, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $99.9K |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $103K |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $706 |
| Feb 2, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $124K |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $179K |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $724K |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold (not open market) | $345K |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | — |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | — |
| Jan 2, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $124K |
| Dec 1, 2025 | XERS Xeris Biopharma Holdings, Inc | Sold | $117K |
| Nov 11, 2025 | XERS Xeris Biopharma Holdings, Inc | Sold | $123K |